The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
Explore the future of organ transplants and how biotech innovations like 3D bioprinting and stem cells can solve the organ ...
Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.It ...
Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...
Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...
Omeros (OMER) announced statistical analysis results related to the expanded access program for narsoplimab, Omeros’ monoclonal antibody ...
Losing around 50 to 100 hair strands in a day should not get you overly concerned. However, seeing more scalp than hair is ...
Nonselective β-blockers may delay haematopoietic cell engraftment after transplantation, especially when combined with ...
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
February 14, 2025 - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented ...
Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations ...